Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation
- 1 August 2006
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 23 (2) , 481-489
- https://doi.org/10.1016/j.nbd.2006.04.005
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Nicotinic Cholinergic Receptors in the Rat Cerebellum: Multiple Heteromeric SubtypesJournal of Neuroscience, 2005
- Expression of Nigrostriatal α6-Containing Nicotinic Acetylcholine Receptors Is Selectively Reduced, but Not Eliminated, by β3 Subunit Gene DeletionMolecular Pharmacology, 2005
- Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamusExperimental Neurology, 2005
- Neuronal nicotinic receptors: from structure to pathologyProgress in Neurobiology, 2004
- Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum.Neuroscience Letters, 2004
- α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's DiseaseJournal of Neurochemistry, 1999
- The Neuropsychiatric InventoryNeurology, 1994
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975